InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001104659-23-011206 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-06 2023-02-02 ALT Garg Vipin K Pres, CEO, Dir F - Tax $15.04 -8,422 249.1K -3% -$126.7K
D 2023-02-06 2023-02-02 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 +18.9K 257.6K +8% $0
D 2023-02-06 2023-02-02 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 -18.9K 56.9K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2023-02-02 F D 8,422 $15.04 249,129 D — —
2 Common Common Stock, par value $0.0001 2023-02-02 M A 18,950 $0.00 257,551 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
3 Derivative Restricted Stock Units 2023-02-02 M D 18,950 $0.00 56,850 D — · — to — 18,950 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.